SG11201708399WA - Methods of treating diseases - Google Patents
Methods of treating diseasesInfo
- Publication number
- SG11201708399WA SG11201708399WA SG11201708399WA SG11201708399WA SG11201708399WA SG 11201708399W A SG11201708399W A SG 11201708399WA SG 11201708399W A SG11201708399W A SG 11201708399WA SG 11201708399W A SG11201708399W A SG 11201708399WA SG 11201708399W A SG11201708399W A SG 11201708399WA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- treating diseases
- diseases
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562147281P | 2015-04-14 | 2015-04-14 | |
US201562220385P | 2015-09-18 | 2015-09-18 | |
PCT/US2016/027263 WO2016168282A1 (en) | 2015-04-14 | 2016-04-13 | Methods of treating diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201708399WA true SG11201708399WA (en) | 2017-11-29 |
Family
ID=55911058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201708399WA SG11201708399WA (en) | 2015-04-14 | 2016-04-13 | Methods of treating diseases |
Country Status (16)
Country | Link |
---|---|
US (4) | US20160304602A1 (de) |
EP (3) | EP3283109A1 (de) |
JP (1) | JP2018512422A (de) |
KR (1) | KR20170135972A (de) |
CN (1) | CN107530425A (de) |
AU (1) | AU2016247921A1 (de) |
BR (1) | BR112017018574A2 (de) |
CA (1) | CA2977534A1 (de) |
CL (1) | CL2017002304A1 (de) |
EA (1) | EA201792282A1 (de) |
HK (2) | HK1243937A1 (de) |
IL (1) | IL253847A0 (de) |
MX (1) | MX2017013156A (de) |
PH (1) | PH12017501872A1 (de) |
SG (1) | SG11201708399WA (de) |
WO (1) | WO2016168282A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018135328A (ja) * | 2017-02-21 | 2018-08-30 | 地方独立行政法人青森県産業技術センター | TNFα産生抑制剤 |
CN113621558A (zh) * | 2021-09-08 | 2021-11-09 | 上海万何圆生物科技有限公司 | 一种新鲜肝组织切片的体外培养方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
EP0435911B1 (de) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (de) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformationsvektoren für Hefe Yarrowia |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
DK0590058T3 (da) | 1991-06-14 | 2004-03-29 | Genentech Inc | Humaniseret heregulin-antistof |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
ATE196606T1 (de) | 1992-11-13 | 2000-10-15 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörpern, die gegen ein differenzierung-antigen gerichtet sind, dessen expression auf menschliche b lymphozyt beschränkt ist, für die behandlung von b-zell-lymphoma |
US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
EP1896073B1 (de) | 2005-06-30 | 2013-03-06 | Janssen Biotech, Inc. | Anti-il-23-antikörper, zusammensetzungen, verfahren und verwendung |
MX2008002179A (es) | 2005-08-25 | 2008-04-22 | Lilly Co Eli | Anticuerpos anti-il-23. |
ES2619845T3 (es) | 2005-08-31 | 2017-06-27 | Merck Sharp & Dohme Corp. | Anticuerpos anti-IL-23 diseñados por ingeniería genética |
ES2517420T3 (es) | 2005-12-29 | 2014-11-03 | Janssen Biotech, Inc. | Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos |
WO2007147019A2 (en) * | 2006-06-13 | 2007-12-21 | Zymogenetics, Inc. | Il-17 and il-23 antagonists and methods of using the same |
HUE042172T2 (hu) | 2007-02-23 | 2019-06-28 | Merck Sharp & Dohme | Genetikailag elõállított anti-il-23P19 antitestek |
CN103282382B (zh) | 2010-11-04 | 2017-11-03 | 勃林格殷格翰国际有限公司 | 抗il‑23抗体 |
US9078894B2 (en) * | 2011-02-04 | 2015-07-14 | Ab Science | Treatment of severe persistant asthma with masitinib |
KR102124758B1 (ko) * | 2012-05-03 | 2020-06-19 | 베링거 인겔하임 인터내셔날 게엠베하 | 항-il-23p19 항체 |
-
2016
- 2016-04-13 EP EP16720609.3A patent/EP3283109A1/de not_active Withdrawn
- 2016-04-13 BR BR112017018574-1A patent/BR112017018574A2/pt not_active Application Discontinuation
- 2016-04-13 MX MX2017013156A patent/MX2017013156A/es unknown
- 2016-04-13 CN CN201680021688.9A patent/CN107530425A/zh active Pending
- 2016-04-13 WO PCT/US2016/027263 patent/WO2016168282A1/en active Application Filing
- 2016-04-13 EP EP18173790.9A patent/EP3391905A1/de not_active Withdrawn
- 2016-04-13 US US15/097,722 patent/US20160304602A1/en not_active Abandoned
- 2016-04-13 JP JP2017551277A patent/JP2018512422A/ja active Pending
- 2016-04-13 AU AU2016247921A patent/AU2016247921A1/en not_active Abandoned
- 2016-04-13 EA EA201792282A patent/EA201792282A1/ru unknown
- 2016-04-13 KR KR1020177033007A patent/KR20170135972A/ko unknown
- 2016-04-13 CA CA2977534A patent/CA2977534A1/en not_active Abandoned
- 2016-04-13 EP EP20156338.4A patent/EP3685856A1/de not_active Withdrawn
- 2016-04-13 SG SG11201708399WA patent/SG11201708399WA/en unknown
-
2017
- 2017-08-06 IL IL253847A patent/IL253847A0/en unknown
- 2017-08-25 US US15/686,365 patent/US20180009887A1/en not_active Abandoned
- 2017-09-12 CL CL2017002304A patent/CL2017002304A1/es unknown
- 2017-10-13 PH PH12017501872A patent/PH12017501872A1/en unknown
-
2018
- 2018-03-13 HK HK18103493.6A patent/HK1243937A1/zh unknown
- 2018-03-13 HK HK18114879.7A patent/HK1255728A1/zh unknown
- 2018-06-27 US US16/019,670 patent/US20180334501A1/en not_active Abandoned
-
2019
- 2019-03-08 US US16/297,563 patent/US20190359701A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HK1255728A1 (zh) | 2019-08-23 |
JP2018512422A (ja) | 2018-05-17 |
US20160304602A1 (en) | 2016-10-20 |
HK1243937A1 (zh) | 2018-07-27 |
MX2017013156A (es) | 2018-02-21 |
BR112017018574A2 (pt) | 2018-04-17 |
EA201792282A1 (ru) | 2018-04-30 |
KR20170135972A (ko) | 2017-12-08 |
AU2016247921A1 (en) | 2017-08-31 |
US20180334501A1 (en) | 2018-11-22 |
PH12017501872A1 (en) | 2018-02-26 |
EP3283109A1 (de) | 2018-02-21 |
EP3391905A1 (de) | 2018-10-24 |
EP3685856A1 (de) | 2020-07-29 |
WO2016168282A1 (en) | 2016-10-20 |
US20190359701A1 (en) | 2019-11-28 |
IL253847A0 (en) | 2017-09-28 |
CN107530425A (zh) | 2018-01-02 |
CL2017002304A1 (es) | 2018-05-18 |
US20180009887A1 (en) | 2018-01-11 |
CA2977534A1 (en) | 2016-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251408A1 (zh) | 治療癌症的方法 | |
IL259783A (en) | Methods of treatment of malignant diseases | |
IL260199B (en) | Cancer treatment methods | |
IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
HK1246179A1 (zh) | 治療視網膜疾病的方法 | |
GB201701673D0 (en) | Methods of well treatment | |
IL253118A0 (en) | Methods for treating inflammatory diseases | |
HK1248552A1 (zh) | 使用川地匹坦的治療方法 | |
HK1252037A1 (zh) | 治療炎性疾病的方法 | |
HK1247818A1 (zh) | 治療疾病的方法 | |
HK1258994A1 (zh) | 用於疾病治療的方法 | |
GB201410116D0 (en) | Method of treatment | |
IL253028A0 (en) | treatment method | |
GB201416832D0 (en) | Methods of treatment | |
HK1249866A1 (zh) | 用他塞利昔布進行治療的方法 | |
GB201602802D0 (en) | Method of treatment | |
HK1243937A1 (zh) | 治療疾病的方法 | |
HK1246679A1 (zh) | 絲蟲病的治療 | |
GB201512139D0 (en) | Methods of treatment | |
GB201511017D0 (en) | Method of treatment | |
GB201504413D0 (en) | Treatment of disease | |
GB201421982D0 (en) | Method of treatment | |
GB201421980D0 (en) | Method of treatment | |
GB201415331D0 (en) | Method of treatment | |
GB201414780D0 (en) | Method Of Treatment |